<SEC-DOCUMENT>0001104659-20-102336-index.html : 20200903
<SEC-HEADER>0001104659-20-102336.hdr.sgml : 20200903
<ACCEPTANCE-DATETIME>20200903184857
ACCESSION NUMBER:		0001104659-20-102336
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200901
FILED AS OF DATE:		20200903
DATE AS OF CHANGE:		20200903

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Swirsky Douglas J
		CENTRAL INDEX KEY:			0001375884

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		201160299

	MAIL ADDRESS:	
		STREET 1:		C/O REXAHN PHARMACEUTICALS, INC.
		STREET 2:		15245 SHADY GROVE ROAD SUITE 455
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>a4.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: a4.html

Document 1 - RAW XML: a4.xml

</DOCUMENT>
</SEC-DOCUMENT>